Possible role of trace elements in epilepsy and febrile seizures: A meta-analysis

Nutrition Reviews

Volumn 73, Issue 11, 2015, Pages 760-779

  Saghazadeh, Amene ^a   Mahmoudi, Maryam ^b   Meysamie, Alipasha ^c   Gharedaghi, Maryam ^a   Zamponi, Gerald W ^d   Rezaei, Nima ^a,e,f,g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF CALGARY   (Canada)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f Universal Scientific Education and Research Network   (Iran)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antiepileptic drugs; Copper; Epilepsy; Febrile seizures; Magnesium; Meta analysis; Selenium; Zinc

Indexed keywords

ANTICONVULSIVE AGENT; COPPER; MAGNESIUM; SELENIUM; TRACE ELEMENT; ZINC;

ANTICONVULSANT THERAPY; ARTICLE; CEREBROSPINAL FLUID; COPPER BLOOD LEVEL; EPILEPSY; FEBRILE CONVULSION; HAIR LEVEL; HOMEOSTASIS; HUMAN; MAGNESIUM BLOOD LEVEL; META ANALYSIS; MONOTHERAPY; SELENIUM BLOOD LEVEL; TREATMENT RESPONSE; ZINC BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; SEIZURES, FEBRILE;

CASE-CONTROL STUDIES; EPILEPSY; HUMANS; SEIZURES, FEBRILE; TRACE ELEMENTS;

EID: 84947792929     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv026     Document Type: Article

References (310)

1. Fu LY, Moon RY. Apparent life-threatening events: an update. Pediatr Rev. 2012;33:361-368; quiz 368-369.
2. Guidelines for Epidemiologic Studies on Epilepsy. Epilepsia. 1993;34:592-596.
3. Baldin E, Ludvigsson P, Mixa O, et al. Prevalence of recurrent symptoms and their association with epilepsy and febrile seizure in school-aged children: a community-based survey in Iceland. Epilepsy Behav. 2012;23:315-319.
4. Kundu GK, Rabin F, Nandi E, et al. Etiology and risk factors of febrile seizure-an update. Bangladesh J Child Health 2010;34:103-112.
5. Salzmann A, Guipponi M, Lyons PJ, et al. Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy. Hum Mutat. 2012;33:124-135.
6. Nakayama J, Arinami T. Molecular genetics of febrile seizures. Epilepsy Res. 2006;70(suppl 1):S190-S198.
7. Kanemura H, Mizorogi S, Aoyagi K, et al. EEG characteristics predict subsequent epilepsy in children with febrile seizure. Brain Dev. 2012;34:302-307.
8. Fisher RS, Boas WVE, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470-472.
9. Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129:256-264.
10. Gaitatzis A, Carroll K, Majeed A, et al. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:1613-1622.
11. Johnson EK, Jones JE, Seidenberg M, et al. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia. 2004;45:544-550.
12. Gilliam F, Hecimovic H, Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav. 2003;4(suppl. 4):26-30.
13. Devinsky O. Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment. Epilepsy Behav. 2003;4(suppl. 4):2-10.
14. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5:148-157.
15. Meyer A-C, Dua T, Ma J, et al. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ. 2010;88:260-266.
16. Rolls ET, Treves A, Rolls ET. Neural Networks and Brain Function. Oxford: Oxford University Press; 1998.
17. Engelborghs S, D'Hooge R, De Deyn P. Pathophysiology of epilepsy. Acta Neurol Belg. 2000;100:201-213.
18. Sutula TP. Mechanisms of epilepsy progression: current theories and perspectives from neuroplasticity in adulthood and development. Epilepsy Res. 2004;60:161-171.
19. Bitanihirwe BKY, Cunningham MG. Zinc: the brain's dark horse. Synapse. 2009;63:1029-1049.
20. Mathie A, Sutton GL, Clarke CE, et al. Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol Ther. 2006;111:567-583.
21. Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 2003;189:147-163.
22. Yuen AWC, Sander JW. Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis. Epilepsy Res. 2012;100:152-156.
23. Schweizer U, Braüer AU, Köhrle J, et al. Selenium and brain function: a poorly recognized liaison. Brain Res Rev. 2004;45:164-178.
24. Savaskan NE, Braüer AU, Kühbacher M, et al. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB J. 2003;17:112-114.
25. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233-241.
26. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1987;1:441-445.
27. Sirikonda NS, Patten WD, Phillips JR, et al. Ketogenic diet: rapid onset of selenium deficiency-induced cardiac decompensation. Pediatr Cardiol. 2012;33:834-838.
28. Terra VC, De Albuquerque M, Scorza CA, et al. Serum magnesium: a clinical biomarker for sudden unexpected death in epilepsy? J Epilepsy Clin Neurophysiol. 2011;17:75-77.
29. Marco EJ, Anderson JE, Neilson DE, et al. Acute necrotizing encephalopathy in 3 brothers. Pediatrics. 2010;125:e693-e698.
30. Tam EWY, Feigenbaum A, Addis JBL, et al. A novel mitochondrial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis. Neuropediatrics. 2008;39:328-334.
31. Gandhi M, Vern AK, An G, et al. Blister fluid composition in a pediatric patient with toxic epidermal necrolysis. J Burn Care Res. 2008;29:671-675.
32. Mazor SS, Feldman KW, Sugar NF, et al. Pediatric tramadol ingestion resulting in seizurelike activity: a case series. Pediatr Emerg Care. 2008;24:380-381.
33. Bindu PS, Sinha S, Taly AB, et al. Menkes syndrome presenting as myoclonic seizures: neuroimaging and EEG observations. J Child Neurol. 2007;22:452-455.
34. Mizuguchi M, Itoh M, Ozawa H, et al. A 2-year-old boy with hypoactivity of neonatal onset and profound developmental delay. Neuropathology. 2007;27:145-149.
35. Agertt F, Crippa ACS, Lorenzoni PJ, et al. Menkes' disease: case report. Arquivos de Neuro-Psiquiatria. 2007;65:157-160.
36. Fister P, Rakuš J, Primec ZR, et al. Menkes kinky hair disease (Menkes syndrome). A case report. Acta Dermatovenerol Alp Pannonica et Adriat. 2006;15:126-130.
37. Visudhiphan P, Visudtibhan A, Chiemchanya S, et al. Neonatal seizures and familial hypomagnesemia with secondary hypocalcemia. Pediatric Neurol. 2005;33:202-205.
38. Meek MF, Broekroelofs J, Yska JP, et al. Valproic acid intoxication: sense and nonsense of haemodialysis. Neth J Med. 2004;62:333-336.
39. Gérard-Blanluet M, Birk-Møller L, Horn N, et al. Early development of occipital horns in a classical Menkes patient. Am J Med Genet. 2004;130A:211-213.
40. Von Einsiedel RW, Roesch-Ely D, Diebold K, et al. H2-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. Pharmacopsychiatry. 2002;35:152-154.
41. Takahata M, Hashino S, Izumiyama K, et al. Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. Bone Marrow Transpl. 2001;28:713-715.
42. Jayawant S, Halpin S, Wallace S. Menkes kinky hair disease: an unusual case. Eur J Paediat Neurol. 2000;4:131-134.
43. Dimario FJ Jr. Childhood head tremor. J Child Neurol. 2000;15:22-25.
44. Alli N, Güngör E. Keratitis, ichthyosis and deafness (KID) syndrome. Int J Dermatol. 1997;36:37-40.
45. Tokuda K, Kodani N, Ogino T. Three cases of hypofibrinogenemia induced by chemotherapy with a combination of synthetic ACTH and valproic acid [article in Japanese]. No To Hattatsu. 1994;26:50-56.
46. Bratter P, Brunetto R, Gramm HJ, et al. Detection of HPLC-ICP of metallothionein in serum of an epileptic child with valproate-associated hepatotoxicity. J Trace Elem Electrolytes Health Dis. 1992;6:251-255.
47. Huddle KRL. Cardiac dysfunction in primary hypoparathyroidism. A report of 3 cases. S Afr Med J. 1988;73:242-244.
48. Inagaki M, Hashimoto K, Yoshino K, et al. Atypical form of Menkes kinky hair disease with mitochondrial NADH-CoQ reductase deficiency. Neuropediatrics. 1988;19:52-55.
49. Matthey F, Gelder CM, Schon FEG. Isolated hypomagnesaemia presenting as focal seizures in diabetes mellitus. Brit Med J. 1986;293:1409. doi:10.1136/bmj.293.6559.1409.
50. Wason S, Savitt D. Acute valproic acid toxicity at therapeutic concentrations. Clin Pediatr. 1985;24:466-467.
51. Argent AC, Rothberg AD, Pienaar N. Precursor prothrombin status in two mother-infant pairs following gestational anticonvulsant therapy. Pediatr Pharmacol. 1984;4:183-187.
52. Campbell WW Jr. Periodic alternating nystagmus in phenytoin intoxication. Arch Neurol. 1980;37:178-180.
53. Jooste PL, Wolfswinkel JM, Schoeman JJ, et al. Epileptic-type convulsions and magnesiumdeficiency. Aviat Space Environ Med. 1979;50:734-735.
54. Guilleminault C, Harpey JP, Lafourcade J. Sjogren Larsson syndrome. Report of two cases in twins. Neurology. 1973;23:367-373.
55. Shiva S, Barzegar M, Zokaie N, et al. Dose supplemental zinc prevents recurrence of febrile seizures? Iran J Child Neurol. 2011;5:11-14.
56. Baraka AM, Hassab El Nabi W, El Ghotni S. Investigating the role of zinc in a rat model of epilepsy. CNS Neurosci Ther. 2012;18:327-333.
57. Holtkamp M, Buchheim K, Elsner M, et al. Status epilepticus induces increasing neuronal excitability and hypersynchrony as revealed by optical imaging. Neurobiol Dis. 2011;43:220-227.
58. Heshmatian B, Roshan-Milani S, Saboory E. Prenatal acute stress attenuated epileptiform activities in neonate mice. Yakhteh Med J. 2010;12:81-86.
59. Kutluhan S, Naziroğlu M, Çelik O, et al. Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazolinduced epileptic rats. Biol Trace Elem Res. 2009;129:181-189.
60. 2+-ATPase activity, and EEG records in pentylentetrazol-induced seizures in rats. J Membr Biol. 2008;225:39-49.
61. Motamedi GK, Salazar P, Smith EL, et al. Termination of epileptiform activity by cooling in rat hippocampal slice epilepsy models. Epilepsy Res. 2006;70:200-210.
62. Kirby BP, Shaw GG. Effect of spermine and N1-dansyl-spermine on epileptiform activity in mouse cortical slices. Eur J Pharmacol. 2005;524:53-59.
63. 2+-induced epileptiform activity in the entorhinal cortex. Epilepsia. 2005;46:509-516.
64. Świader M, Wielosz M, Czuczwar SJ. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol. 2004;14:307-318.
65. Wang T, Wang J, Cottrell JE, et al. Small physiologic changes in calciumand magnesium alter excitability and burst firing of CA1 pyramidal cells in rat hippocampal slices. J Neurosurg Anesthesiol. 2004;16:201-209.
66. Duffy S, Nguyen PV, Baker GB. Phenylethylidenehydrazine, a novel GABA-transaminase inhibitor, reduces epileptiform activity in rat hippocampal slices. Neuroscience. 2004;126:423-432.
67. Yang ZX, Qin J. Interaction between endogenous nitric oxide and carbonmonoxide in the pathogenesis of recurrent febrile seizures. Biochem Biophys Res Commun. 2004;315:349-355.
68. Nyikos L, Lasztóczi B, Antal K, et al. Desynchronisation of spontaneously recurrent experimental seizures proceeds with a single rhythm. Neuroscience. 2003;121:705-717.
69. Luszczki J, Świader M, Czuczwar M, et al. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol Biochem Behav. 2003;75:319-327.
70. Moddel G, Gorji A, Speckmann EJ. Background potassiumconcentrations and epileptiform discharges: I. Electrophysiological characteristics of neuronal activity. Brain Res. 2003;959:135-148.
71. Gorji A, Moddel G, Speckmann EJ. Background potassium concentrations and epileptiform discharges: II. Involvement of calcium channels. Brain Res. 2003;959:149-159.
72. 2+-induced epileptiform activity in rat hippocampal-entorhinal cortex slices. Neurob Dis. 2002;11:96-105.
73. Gorji A, Scheld HH, Speckmann EJ. Epileptogenic effect of cyclosporine in guinea-pig hippocampal slices. Neuroscience. 2002;115:993-997.
74. Doretto MC, Simões S, Paiva AMR, et al. Zinc, magnesium and copper profiles in three experimental models of epilepsy. Brain Res. 2002;956:166-172.
75. Schuchmann S, Meierkord H, Stenkamp K, et al. Synaptic and nonsynaptic ictogenesis occurs at different temperatures in submerged and interface rat brain slices. J Neurophysiol. 2002;87:2929-2935.
76. Naish HJ, Marsh WL, Davies JA. Effect of low-affinity NMDA receptor antagonists on electrical activity in mouse cortical slices. Eur J Pharmacol. 2002;443:79-83.
77. Schuchmann S, Kovacs R, Kann O, et al. Monitoring NAD(P)H autofluorescence to assess mitochondrial metabolic functions in rat hippocampal-entorhinal cortex slices. Brain Res Brain Res Protoc. 2001;7:267-276.
78. Carrasco J, Penkowa M, Hadberg H, et al. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice. Eur J Neurosci. 2000;12:2311-2322.
79. Lynch M, Sutula T. Recurrent excitatory connectivity in the dentate gyrus of kindled and kainic acid-treated rats. J Neurophysiol. 2000;83:693-704.
80. De Sarro G, Gratteri S, Bonacci F, et al. Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol. 2000;388:163-170.
81. Otoom SA, Alkadhi KA. Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons. Neurosci Res. 1999;35:299-307.
82. 2+-induced epileptiform activity in organotypic hippocampal slice cultures. Neuroreport. 1999;10:207-213.
83. Slutzky MW, Mogul DJ. Chaotic behavior in two hippocampal models of epilepsy. In: Proceedings of the 20th Annual International Conference of the IEEE. Hong Kong: Institute of Electrical and Electronics Engineers;1998.
84. Al-Ghoul WM, Meeker RB, Greenwood RS. Kindled seizures increase metabotropic glutamate receptor expression and function in the rat supraoptic nucleus. J Neurosci Res. 1998;54:412-423.
85. Chesi AJR, Stone TW. Epileptiform activity in supragranular and infragranular blocks of mouse neocortex. Epilepsy Res. 1998;31:29-38.
86. Behr J, Lyson KJ, Mody I. Enhanced propagation of epileptiform activity through the kindled dentate gyrus. J Neurophysiol. 1998;79:1726-1732.
87. Czuczwar SJ, Gasior M, Kamiński R, et al. GYKI 52466 [1-(4-aminophenyl)-4-methoxy-7, 8-methylenedioxy-5H-2, 3-benzodiazepine hydrochloride] and the anticonvulsive activity of conventional antiepileptics against pentetrazol in mice. Mol Chem Neuropathol. 1998;33:149-162.
88. Grunze H, Walden J. Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs. Magnes Res. 1997;10:119-126.
89. Borowicz KK, Gasior M, Kleinrok Z, et al. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia. 1996;37:618-624.
90. Dodman NH, Knowles KE, Shuster L, et al. Behavioral changes associated with suspected complex partial seizures in bull terriers. J Am Vet Med Assoc. 1996;208:688-691.
91. Vick RS, Rafiq A, Coulter DA, et al. GABA(A) a2 mRNA levels are decreased following induction of spontaneous epileptiform discharges in hippocampal-entorhinal cortical slices. Brain Res. 1996;721:111-119.
92. Baydas G, Donder E, Akyol A, et al. Increased resistance to the convulsive effects of penthylenetetrazol in the hyperammonemic dogs with hepatic failure. Turk J Med Sci. 1996;26:227-230.
93. Apland JP, Cann FJ. Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal slices. Brain Res Bull. 1995;37:311-316.
94. Avoli M, Louvel J, Drapeau C, et al. GABA(A)-mediated inhibition and in vitro epileptogenesis in the human neocortex. J Neurophysiol. 1995;73:468-484.
95. Borowicz KK, Gasior M, Kleinrok Z, et al. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol. 1995;281:319-326.
96. Sittsworth JD Jr, Lanthorn TH. Lactate mimics only some effects of D-glucose on epileptic depolarization and long-term synaptic failure. Brain Res. 1993;630:21-27.
97. Zarnowski T, Kleinrok Z, Turski WA, et al. 2, 3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. Neuropharmacology. 1993;32:895-900.
98. Czuczwar SJ, Gasior M, Janusz W, et al. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology. 1992;31:1179-1183.
99. Zia-Gharib F, Webster RA. Effect of compounds modulating amino acid neurotransmission on the development and control of bicuculline-induced epileptogenic spiking in the rat. Neuropharmacology. 1991;30:995-1009.
100. Czuczwar SJ, Malek U, Kleinrok Z. Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazolinduced convulsions in mice. Neuropharmacology. 1990;29:943-948.
101. Czuczwar SJ, Gasior M, Janusz W, et al. Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia. 1990;31:318-323.
102. Krauss GL, Kaplan P, Fisher RS. Parenteral magnesium sulfate fails to control electroshock and pentylenetetrazol seizures in mice. Epilepsy Res. 1989;4:201-206.
103. Heiskala H, Gutteridge JM, Westermarck T, et al. Bleomycin-detectable iron and phenanthroline-detectable copper in the cerebrospinal fluid of patients with neuronal ceroid-lipofuscinoses. Am J Med Genet. Suppl. 1988;5:193-202.
104. Ashton D, De Prins E, Willems R, et al. Anticonvulsant action of the nucleoside transport inhibitor, soluflazine, on synaptic and non-synaptic epileptogenesis in the guinea-pig hippocampus. Epilepsy Res. 1988;2:65-71.
105. Sterman MB, Shouse MN, Fairchild MD, et al. Kindled seizure induction alters and is altered by zinc absorption. Brain Res. 1986;383:382-386.
106. Palm R, Hallmans G, Wahlstrom G. Effects of long-term phenytoin treatment on brain weight and zinc and copper metabolism in rats. Neurochem Pathol. 1986;5:87-106.
107. Alley MC, Killam EK, Fisher GL. The influence of D-penicillamine treatment upon seizure activity and trace metal status in the Senegalese baboon, Papio papio. J Pharmacol Exp Ther. 1981;217:138-146.
108. Massie HR, Colacicco JR, Aiello VR. Phenytoin-induced serum copper and ceruloplasmin in C57BL/6Jmice of different ages. Age. 1980;3:33-37.
109. Bierkamper GG, Cenedella RJ. Cerebral cortical cholesterol changes in cobalt-induced epilepsy. Epilepsia. 1978;19:155-167.
110. Morava E, Gergely A, Tarjan R. Influence of dietary cadmium and copper on the rachitogenic effect of some anticonvulsants in rats. Nutr Metabol. 1977;21(suppl. 1):225-228.
111. Barbeau A, Donaldson J. Zinc, taurine, and epilepsy. Arch Neurol. 1974;30:52-58.
112. Shahar E, Derchansky M, Carlen PL. The role of altered tissue osmolality on the characteristics and propagation of seizure activity in the intact isolated mouse hippocampus. Clin Neurophysiol. 2009;120:673-678.
113. Schwechter EM, Veliskova J, Velisek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol. 2003;53:91-101.
114. Kuzuya T, Amioka K, Nabeshima T. Valproic acid increases biliary copper excretion in the rat. Epilepsy Res. 2002;51:279-285.
115. Kodama H, Fujisawa C, Bhadhprasit W. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment. Curr Drug Metabol. 2012;13:237-250.
116. Wahab A, Albus K, Gabriel S, et al. In search of models of pharmacoresistant epilepsy. Epilepsia. 2010;51(suppl. 3):154-159.
117. Eby GA III, Eby KL. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses. 2010;74:649-660.
118. Shorvon SD. Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958. Epilepsia. 2009;50(suppl. 3):69-92.
119. Newton CR, Neville BG. Paediatric neurology: advances on many fronts. Lancet Neurol. 2009;8:14-15.
120. Johannessen SI. Can pharmacokinetic variability be controlled for the patient's benefit? The place of TDM for new AEDs. Ther Drug Monit. 2005;27:710-713.
121. Stewart CE. Anticonvulsant medications. Emerg Med Serv. 2001;30:56-66; quiz 86.
122. Van der Meyden CH, Rodda JL. Epilepsy management at primary health care level. S Afr Med J. 2000;90:403-432.
123. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenias. J Orthomol Med. 1999;14:28-48.
124. Young WB. Migraine treatment. Semin Neurol. 1997;17:325-332.
125. Mukhdomi GJ, Desai MH, Herndon DN. Seizure disorders in burned children: a retrospective review. Burns. 1996;22:316-319.
126. McLean MJ. Gabapentin. Epilepsia. 1995;36(suppl. 2):S73-S86.
127. Vince JD. Convulsions in children. P N G Med J. 1992;35:144-151.
128. Leaver DD, Parkinson GB, Schneider KM. Neurological consequences of magnesium deficiency: correlations with epilepsy. Clin Exp Pharmacol Physiol. 1987;14:361-370.
129. Sorenson JRJ, Kishore V, Pezeshk A, et al. Copper complexes: a physiological approach to the treatment of 'inflammatory diseases. Inorg Chim Acta. 1984;91:285-294.
130. Aston B. Manganese andman. J Orthomol Psychiatr. 1980;9:237-249.
131. Victor M. The role of hypomagnesemia and respiratory alkalosis in the genesis of alcohol withdrawal symptoms. Ann N Y Acad Sci. 1973;215:235-248.
132. Koppel BS. Treatment of acute and remote symptomatic seizures. Curr Treat Options Neurol. 2009;11:231-241.
133. Lerner PI, Smith H, Weinstein L. Penicillin neurotoxicity. Ann N Y Acad Sci. 1967;145:310-318.
134. Rawson MD. Diphenylhydantoin intoxication and cerebrospinal fluid protein. Neurology. 1968;18:1009-1011.
135. Seal US, Eist H. Serum magnesium concentration in schizophrenia and epilepsy. Clin Chem. 1967;13:1021-1023.
136. Rabbani MW, Ali I, Latif HZ, et al. Serum zinc level in children presenting with febrile seizures. Pak J Med Sci. 2013;29.
137. Per H, Canpolat M, Sahin U, et al. Serum and urine boron and selenium levels in children with resistant epilepsy. Saudi Med J. 2012;33:942-947.
138. Ilhan A, Özerol E, Güleç M, et al. The comparison of nail and serum trace elements in patients with epilepsy and healthy subjects. Prog Neuropsychopharmacol Biol Psychiatr. 2004;28:99-104.
139. Bachtler K, Dralle D. Magnesium in cerebro-spinal-fluid (CSF) of preterm infants with seizures. Magnes Bull. 1997;19:1-3.
140. Ward KP, Arthur JR, Russell G, et al. Blood selenium content and glutathione peroxidase activity in children with cystic fibrosis, coeliac disease, asthma, and epilepsy. Eur J Pediatr. 1984;142:21-24.
141. Krishnamoorthy G, Nair R, Sundar U, et al. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study. Neurol India. 2010;58:213-219.
142. Donaldson D, Trotman H, Barton M, et al. Routine laboratory investigations in infants and children presenting with fever and seizures at the University Hospital of the West Indies. West Indian Med J. 2008;57:369-372.
143. Prasad R, Anil, Mishra OP, et al. Oxidative stress in children with neurocysticercosis. Pediatr Infect Dis J. 2012;31:1012-1015.
144. Lampon N, Tutor JC. A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid. Upsala J Med Sci. 2011;116:148-154.
145. Lambrinoudaki I, Kaparos G, Armeni E, et al. Bsml vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on longterm antiepileptic therapy. Eur J Neurol. 2011;18:93-98.
146. Triantafyllou N, Lambrinoudaki I, Armeni E, et al. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy. J Neurol Sci. 2010;290:131-134.
147. Almenabbawy KM, Helal SI, Zaki ST, et al. IS balanced diet has effect on epileptics? J Med Sci. 2009;9:234-239.
148. Christiansen C, Naestoft J, Hvidberg EF, et al. An easy procedure for in vivo estimation of protein binding and correction of elevated serum values induced by venous stasis. Clinica Chimica Acta. 1975;62:65-71.
149. Ravikumar A, Deepadevi KV, Arun P, et al. Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders. Neurol India. 2000;48:231-238.
150. Christiansen C, Brandt NJ, Ebbesen F, et al. Do newborns of epileptics on anticonvulsants develop biochemical signs of osteomalacia? A controlled prospective study. Acta Neurol Scand. 1980;62:158-164.
151. Christodoulides SS, Neal EG, Fitzsimmons G, et al. The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels. J Hum Nutr Diet. 2012;25:16-26.
152. Bergqvist AG, Chee CM, Lutchka L, et al. Selenium deficiency associated with cardiomyopathy: a complication of the ketogenic diet. Epilepsia. 2003;44:618-620.
153. Kurowski HL, Gospe SM Jr, Zeman FJ, et al. Nutritional factors and anticonvulsant therapies: effect on growth in children with epilepsy. Am J Clin Nutr. 1993;58:858-861.
154. Van Calcar SC, Liebl BH, Fischer MH, et al. Long-term nutritional status of an enterally nourished institutionalized population. Am J Clin Nutr. 1989;50:381-390.
155. Yürekli VA, Naziroğlu M. Selenium and topiramate attenuates blood oxidative toxicity in patients with epilepsy: a clinical pilot study. Biol Trace Elem Res. 2013;152:180-186.
156. Rahman MK, Rahman F, Rahman T, et al. Dopamine-b-hydroxylase (DBH), its cofactors and other biochemical parameters in the serum of neurological patients in Bangladesh. Int J Biomed Sci. 2009;5:395-401.
157. Krauss GL, Niedermeyer E. Electroencephalogram and seizures in chronic alcoholism. Electroencephalogr Clin Neurophysiol. 1991;78:97-104.
158. Kuoppala T, Tuimala R, Koskinen T. The effects of long-term anticonvulsant drug therapy on vitamin D metabolites and mineral homeostasis in pregnant epileptic women and their newborns. Ann Chir Gynaecol Suppl. 1985;197:37-41.
159. Hyvönen-Dabek M, Nikkinen-Vilkki P, Dabek JT. Selenium and other elements in human maternal and umbilical serum, as determined simultaneously by protoninduced X-ray emission. Clin Chem. 1984;30:529-533.
160. Meyer JG, Urban K. Electrolyte changes and acid base balance after alcohol withdrawal, with special reference to rum fits and magnesium depletion. J Neurol. 1977;215:135-140.
161. Christiansen C, Rodbro P, Sjo O. 'Anticonvulsant action' of vitamin D in epileptic patients? A controlled pilot study. Brit Med J. 1974;2:258-259.
162. Akyol O. Serum and hair trace element levels in patients with epilepsy and healthy subjects: does the antiepileptic therapy affect the element concentrations of hair? Eur J Neurol. 1999;6:705-709.
163. Akbayram S, Cemek M, Büyükben A, et al. Major and minor bio-element status in children with febrile seizure. Bratisl Lek Listy. 2012;113:421-423.
164. Akbayram S, Cemek M, Büyükben A, et al. Major and minor bio-element status in children with febrile seizure. Bratisl Med J. 2012;113:421-423.
165. Ounjaijean S, Westermarck T, Partinen M, et al. Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. Int J Clin Pharmacol Ther. 2011;49:268-276.
166. Kurup RK, Kurup PA. Schizoid neurochemical pathology-induced membrane Na+-K+ ATPase inhibition in relation to neurological disorders. Int J Neurosci. 2003;113:1705-1717.
167. Kurup RK, Kurup PA. Isoprenoid pathway-related membrane dysfunction in neuropsychiatric disorders. Int J Neurosci. 2003;113:1579-1591.
168. Kurup RK, Kurup PA. Hypothalamic digoxin-mediated model for epileptogenesis. Acta Neuropsychiatrica. 2003;15:115-121.
169. Kumar AR, Kurup PA. Inhibition of membrane Na+-K+ ATPase activity: a common pathway in central nervous system disorders. J Assoc Physicians India. 2002;50:400-406.
170. Kumar AR, Kurup PA. Membrane Na+ K+ ATPase inhibition related dyslipidemia and insulin resistance in neuropsychiatric disorders. Indian J Physiol Pharmacol. 2001;45:296-304.
171. Kurekci AE, Alpay F, Tanindi S, et al. Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia. 1995;36:600-604.
172. Gupta SK, Manhas AS, Gupta VK, et al. Serum magnesium levels in idiopathic epilepsy. J Assoc Physicians India. 1994;42:456-457.
173. Kuzuya T, Hasegawa T, Shimizu K, et al. Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients.Int J Clin Pharmacol Ther Toxicol. 1993;31:61-65.
174. Kaji M, Ito M, Okuno T, et al. Serum copper and zinc levels in epileptic children with valproate treatment. Epilepsia. 1992;33:555-557.
175. Taylor A, Ghose K. Diurnal variation of serum copper and zinc in epileptics receiving anti-convulsants. Hum Toxicol. 1986;5:195-200.
176. Werther CA, Cloud H, Ohtake M, et al. Effect of long-term administration of anticonvulsants on copper, zinc, and ceruloplasmin levels. Drug Nutr Interact. 1986;4:269-274.
177. Yassa R, Schwartz G. Plasma magnesium and anticonvulsant therapy. N Y State J Med. 1984;84:114-115.
178. Palm R, Hallmans G. Zinc and copper metabolism in phenytoin therapy. Epilepsia. 1982;23:453-461.
179. Kumar D, Sharma B, Misra PK, et al. Cerebrospinal fluid cations in convulsive disorders in children. Indian Pediatr. 1979;16:765-769.
180. Taylor JD, Krahn PM, Higgins TN. Serum copper levels and diphenylhydantoin. Am J Clin Pathol. 1974;61:577-578.
181. Brunia CH, Buyze G. Serum copper levels and epilepsy. Epilepsia. 1972;13:621-625.
182. Erminio C, Ferini-Strambi L, Calori G, et al. Effect of chronic antiepileptic treatment on biochemical parameters. Clin Neuropharmacol. 1994;17:199-203.
183. Voudris KA, Attilakos A, Katsarou E, et al. Early alteration in bone metabolism in epileptic children receiving carbamazepine monotherapy owing to the induction of hepatic drug-metabolizing enzymes. J Child Neurol. 2005;20:513-516.
184. Canger R, Guidolin L. Clinical efficacy and tolerability of magnesium valproate as monotherapy in patients with generalised or partial epilepsy: a nonblinded study of 320 patients. Clin Drug Invest. 2000;20:215-221.
185. Castro-Gago M, Pérez-Gay L, Gómez-Lado C, et al. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity. J Child Neurol. 2011;26:1522-1524.
186. Ganesh R, Janakiraman L. Serum zinc levels in children with simple febrile seizure. Clin Pediatr. 2008;47:164-166.
187. Wu HM, Liu CS, Tsai JJ, et al. Antioxidant and anticonvulsant effect of a modified formula of Chaihu-Longu-Muli-Tang. Am J Chinese Med. 2002;30:339-346.
188. Sannita WG. Valproate acute administration, EEG epileptic abnormalities, and ammonemia. Neurology. 1992;42:2003-2005.
189. Fisher RS, Kaplan PW, Krumholz A, et al. Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin Neuropharmacol. 1988;11:537-544.
190. Healy MA, Aslam M. The clinical significance of metal binding in convulsion control with sodium valproate. J Clin Hosp Pharm. 1986;11:189-198.
191. Chandra R, Mahendru RK, Govil MK. Evaluation of serum and cerebrospinal fluid calcium and magnesium levels in cases of epilepsy. Ind Med Gaz. 1984;118:333-335.
192. Bonuccelli U, Buzzigoli G, Ducci M. Plasma levels of calcium, magnesium, and phenobarbital in epileptic and brain trauma patients on chronic therapy. Res Commun Psychol Psychiatr Behav. 1982;7:369-375.
193. Mangal BD, Kumar S, Singh RRP. Some observations on evaluation of serum and cerebrospinal fluid magnesium in cases of epilepsy. Ind Med Gaz. 1980;114:345-346.
194. Laake K, Horvei C, Aspoy B, et al. Hypomagnesaemia during treatment with diuretics. Curr Ther Res Clin Exp. 1978;23:730-733.
195. Vasiliades J, Sahawneh T. Effect of diphebylhydantoin on serum copper, zinc, and magnesium. Clin Chem. 1975;21:637-638.
196. Govil MK, Mangal BD, Alam SM, et al. Serum and cerebrospinal fluid calcium and magnesium levels in cases of idiopathic grand mal epilepsy and induced convulsions. J Assoc Physicians India. 1981;29:695-699.
197. Olatunbosun DA, Akindele MO, Adeniyi FA, et al. Serumcopper and zinc levels in epilepsy. Niger Med J 1978;8:124-125.
198. Jain AC, Krishna R, Bhatia GC. Observations on magnesium levels in serum and cerebrospinal fuid in idiopathic epilepsy. Neurol India. 1970;18:223-225.
199. Pippenger CE, Garlock C, Fernandez F. Effect of antiepileptic drugs on manganese, zinc, copper concentrations in whole blood, RBC and plasma of epileptics. Clin Chem. 1979;25:1111.
200. Christiansen C, Rodbro P, Nielsen SP. Does anticonvulsant hypomagnesaemia exist? Brit Med J. 1976;1:1403.
201. Matin AA, Biparva P, Amanzadeh H, et al. Zinc/aluminum layered double hydroxide-titanium dioxide composite nanosheet film as novel solid phase microextraction fiber for the gas chromatographic determination of valproic acid. Talanta. 2013;103:207-213.
202. Chen D, Lu Y, Yu W, et al. Clinical value of decreased superoxide dismutase 1 in patients with epilepsy. Seizure. 2012;21:508-511.
203. Scorza FA, Cavalheiro EA, Cysneiros RM, et al. Serum magnesiumand sudden unexpected death in epilepsy: a curious clinical sign or a necessity of life. Epilepsy Res. 2012;101:293-294.
204. Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314-2328.
205. Quant H, Arden D, Takoudes T, et al. Angiogenic factors and pregnant woman with new onset seizures. Hypertens Pregnancy. 2012;31:207-210.
206. Ibragic S, Sofic E, Suljic E, et al. Serum nitric oxide concentrations in patients with multiple sclerosis and patients with epilepsy. J Neural Transm. 2012;119:7-11.
207. Frye RE, Naviaux RK. Autistic disorder with complex IV overactivity: a new mitochondrial syndrome. J Pediatr Neurol. 2011;9:427-434.
208. Rossetti AO. What is the value of hypothermia in acute neurologic diseases and status epilepticus? Epilepsia. 2011;52(suppl. 8):64-66.
209. Azizieh R, Orduz D, Van Bogaert P, et al. Progressive myoclonic epilepsyassociated gene KCTD7 is a regulator of potassium conductance in neurons. Mol Neurobiol. 2011;44:111-121.
210. Aidaros M, Goda T, El-Sharkawy KAM. The role of magnesium sulphate in treatment of subarachnoid hemorrhage and its effect on outcome. Egypt J Neurol Psychiatr Neurosurg. 2011;48:79-83.
211. Kalita J, Nair PP, Misra UK. A clinical, radiological and outcome study of status epilepticus from India. J Neurol. 2010;257:224-229.
212. Correa T, Rodríguez I, Romano S. Population pharmacokinetics of valproate in Mexican children with epilepsy. Biopharm Drug Dispos. 2008;29:511-520.
213. Baiocchi M, Grassetto A, Ori C. Potential role of continuous magnesium infusion to prevent vasospasm and consequent ischaemic deficit correlated to subarachnoid haemorrhage. Acta Anaesthesiol Ital. 2006;57:131-145.
214. Inutsuka M, Kobayashi K, Oka M, et al. Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev. 2006;28:281-286.
215. Oby E, Caccia S, Vezzani A, et al. In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: insights into the mechanisms of pharmacoresistance. Brain Res. 2006;1086:201-213.
216. Bahi-Buisson N, Kaminska A, Nabbout R, et al. Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia. 2006;47:380-386.
217. Tutor-Crespo MJ, Hermida J, Tutor JC. Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin. Epilepsy Res. 2003;56:147-153.
218. Kurup RK, Kurup PA. Detection of endogenous lithium in neuropsychiatric disorders-a model for biological transmutation. Human Psychopharmacol. 2002;17:29-33.
219. Ravi Kumar A, Kurup PA. Membrane Na+ K+ ATPase inhibition related dyslipidemia and insulin resistance in neuropsychiatric disorders. Indian J Physiol Pharmacol. 2001;45:296-304.
220. Kurup RKA, Devi D, Augustine J, et al. Alteration in glycoconjugate metabolism in CNS disorders-role of isoprenoid pathway. Neurosci Res Commun. 2001;28:95-106.
221. Scarfone RJ, Pond K, Thompson K, et al. Utility of laboratory testing for infants with seizures. Pediat Emerg Care. 2000;16:309-312.
222. Musshoff U, Köhling R, Lücke A, et al. Vigabatrin reduces epileptiform activity in brain slices from pharmacoresistant epilepsy patients. Eur J Pharmacol. 2000;401:167-172.
223. Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res. 2000;40:33-39.
224. Hals J, Ek J, Svalastog AG, et al. Studies on nutrition in severely neurologically disabled children in an institution. Acta Paediatr. 1996;85:1469-1475.
225. Asconape JJ, Penry JK, Dreifuss FE, et al. Valproate-associated pancreatitis. Epilepsia. 1993;34:177-183.
226. Barkovich AJ, Good WV, Koch TK, et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. Am J Neuroradiol. 1993;14:1119-1137.
227. Bologa M, Tang B, Klein J, et al. Pregnancy-induced changes in drug metabolism in epileptic women. J Pharmacol Exp Ther. 1991;257:735-740.
228. Turnbull TL, Vanden Hoek TL, Howes DS, et al. Utility of laboratory studies in the emergency department patient with a new-onset seizure. Ann Emerg Med. 1990;19:373-377.
229. Colleselli P, Milani M, Drigo P, et al. Impairment of polymorphonuclear leucocyte function during therapy with synthetic ACTH in children affected by epileptic encephalopathies. Acta Paediatr Scand. 1986;75:159-163.
230. Foster AC, Schwarcz R. Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington's disease. J Neurochem. 1985;45:199-205.
231. Thompson CB, June CH, Sullivan KM, et al. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet. 1984;2:1116-1120.
232. Mison Crighel N, Pintilie C, Florescu D. The influence of phenobarbital and diphenylhydantoin on some blood cation transport systems in epileptics. Rev Roum Neurol. 1973;10:451-459.
233. Clausen J, Jensen GE, Nielsen SA. Selenium in chronic neurologic diseases. Multiple sclerosis and Batten's disease. Biol Trace Elem Res. 1988;15:179-203.
234. Abbaskhaniyan A, Shokrzadeh M, Rafati MR, et al. Survey and relation of serum magnesium level in children with seizure. J Mazandaran Univ Med Sci. 2012;22:42-49.
235. Altunbaşak S, Biatmakoui F, Baytok V, et al. Serum and hair zinc levels in epileptic children taking valproic acid. Biol Trace Elem Res. 1997;58:117-125.
236. Amiri M, Farzin L, Moassesi ME, et al. Serum trace element levels in febrile convulsion. Biol Trace Element Res. 2010;135:38-44.
237. Armutcu F, Ozerol E, Gurel A, et al. Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children. Biol Trace Elem Res. 2004;102:1-10.
238. Ashrafi MR, Shabanian R, Abbaskhanian A, et al. Selenium and intractable epilepsy: is there any correlation? Pediatr Neurol. 2007;36:25-29.
239. Ashrafi MR, Shams S, Nouri M, et al. A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis. Epilepsia. 2007;48:1750-1755.
240. Avci H, Kizilkan N, Yaman M. Comparison of trace elements concentrations in scalp hair of epileptic and normal subjects. Trace Elem Electrolytes. 2008;25:147-155.
241. Benga I, Baltescu V, Tilinca R, et al. Plasma and cerebrospinal fluid concentrations of magnesium in epileptic children. J Neurol Sci. 1985;67:29-34.
242. Berk E, Kaya A, Deveci K, et al. Evaluation of serum selenium levels in children with recurrent febril[sic] convulsions [in Turkish]. Güncel Pediatr Dergisi. 2011;9:110-115.
243. Burhanoğlu M, Tütüncüoğlu S, Çoker C, et al. Hypozincaemia in febrile convulsion. Eur J Pediatr. 1996;155:498-501.
244. Çelik K, Çelik Güzel E, Nalbantoğlu B, et al. Serum zinc levels in febrile seizures: is deficiency a risk factor? Turkiye Klinikleri J Pediatr. 2012;21:1-6.
245. Davidson DLW, Ward NI. Abnormal aluminium, cobalt, manganese, strontium and zinc concentrations in untreated epilepsy. Epilepsy Res. 1988;2:323-330.
246. Doneray H, Kara IS, Karakoc A, et al. Serum thyroid hormone profile and trace elements in children receiving valproic acid therapy: a longitudinal and controlled study. J Trace Elem Med Biol. 2012;26:243-247.
247. Ehsanipour F, Talebi-Taher M, Harandi NV, et al. Serum zinc level in children with febrile convulsion and its comparison with that of control group. Iran J Pediatr. 2009;19:65-68.
248. Farahani HN, Ashthiani AR, Masihi MS. Study on serum zinc and selenium levels in epileptic patients. Neurosciences (Riyadh). 2013;18:138-142.
249. Farhad H, Farah A, Ahmad G. Serum zinc level in patients with simple febrile seizure. Iran J Child Neurol. 2010;4:41-44.
250. Ganesh R, Janakiraman L, Meenakshi B. Serum zinc levels are low in children with simple febrile seizures compared with those in children with epileptic seizures and controls. Ann Trop Paediatr. 2011;31:345-349.
251. Garty BZ, Olomucki R, Lerman-Sagie T, et al. Cerebrospinal fluid zinc concentrations in febrile convulsions. Arch Dis Child. 1995;73:338-341.
252. Gündüz Z, Yavuz I, Koparal M, et al. Serum and cerebrospinal fluid zinc levels in children with febrile convulsions. Acta Pediatr Jpn. 1996;38:237-241.
253. Hamed SA, Abdellah MM, El-Melegy N. Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci. 2004;96:465-473.
254. Heipertz R, Eickhoff K, Karstens KH. Cerebrospinal fluid concentrations of magnesium and inorganic phosphate in epilepsy. J Neurol Sci. 1979;41:55-60.
255. Helal SI, Megahed HS, Salem SM, et al. Monotherapy versus polytherapy in epileptic adolescents. Maced J Med Sci. 2013;6:174-177.
256. Ilhan A, Uz E, Kali S, et al. Serum and hair trace element levels in patients with epilepsy and healthy subjects: does the antiepileptic therapy affect the element concentrations of hair? Eur J Neurol. 1999;6:705-709.
257. Khoshdel A, Parvin N, Abbasi M. Selenium and leptin levels in febrile seizure: a case-control study in children. Korean J Pediatr. 2013;56:80-85.
258. Kumar L, Chaurasiya OS, Gupta AH. Prospective study of level of serum zinc in patients of febrile seizures, idiopathic epilepsy and CNS infections. People's J Scientific Res. 2011;4:1-4.
259. Lampón N, Tutor JC. Effect of valproic acid treatment on copper availability in adult epileptic patients. Clin Biochem. 2010;43:1074-1078.
260. Lee JH, Kim JH. Comparison of serum zinc levels measured by inductively coupled plasma mass spectrometry in preschool children with febrile and afebrile seizures. Ann Lab Med. 2012;32:190-193.
261. Lerman-Sagie T, Statter M, Szabo G, et al. Effect of valproic acid therapy on zinc metabolism in children with primary epilepsy. Clin Neuropharmacol. 1987;10:80-86.
262. Liu CS, Wu HM, Kao SH, et al. Phenytoin-mediated oxidative stress in serum of female epileptics: a possible pathogenesis in the fetal hydantoin syndrome. Human Exp Toxicol. 1997;16:177-181.
263. Liu CS, Wu HM, Kao SH, et al. Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy. Clin Neuropharmacol. 1998;21:62-64.
264. Mahyar A, Ayazi P, Dalirani R, et al. A case-control study of the association between serum copper level and febrile seizures in children. Iran J Child Neurol. 2012;6:23-27.
265. Mahyar A, Ayazi P, Fallahi M, et al. Correlation between serum selenium level and febrile seizures. Pediatric Neurol. 2010;43:331-334.
266. Mahyar A, Pahlavan AA, Varasteh-Nejad A. Serum zinc level in children with febrile seizure. Acta Med Iranica. 2008;46:477-480.
267. Margaretha L, Masloman N. Correlation between serum zinc level and simple febrile seizure in children. Paediatr Indones. 2010;50:326-330.
268. Mishra OP, Singhal D, Upadhyay RS, et al. Cerebrospinal fluid zinc, magnesium, copper and gamma-aminobutyric acid levels in febrile seizures. J Pediatr Neurol. 2007;5:39-44.
269. Modarresi MR, Shahkarami SMA, Yaghini O, et al. The relationship between ainc deficiency and febrile convulsion in Isfahan, Iran. Iran J Child Neurol. 2011;5:29-33.
270. Mollah MAH, Dey PR, Tarafdar SA, et al. Zinc in CSF of patients with febrile convulsion. Indian J Pediatr. 2002;69:859-861.
271. Mollah MAH, Rakshit SC, Anwar KS, et al. Zinc concentration in serum and cerebrospinal fluid simultaneously decrease in children with febrile seizure: findings from a prospective study in Bangladesh. Acta Paediatr. 2008;97:1707-1711.
272. Nemati Karimooy HA, Hajzadeh MA, Haidari R, et al. Serum zinc and copper levels in untreated epileptic patients. Pharmacol Online. 2008;2:471-479.
273. Oladipo OO, Ajala MO, Okubadejo N, et al. Plasma magnesium in adult Nigerian patients with epilepsy. Niger Postgrad Med J. 2003;10:234-237.
274. Plonka-Póltorak E, Zagrodzki P, Chlopicka J, et al. Valproic acid modulates superoxide dismutase, uric acid-independent FRAP and zinc in blood of adult epileptic patients. Biol Trace Elem Res. 2011;143:1424-1434.
275. Plonka-Póltorak E, Zagrodzki P, Nicol F, et al. Antioxidant agents and physiological responses in adult epileptic patients treated with lamotrigine. Pharmacol Rep. 2013;65:99-106.
276. Saboktakin L, Barzegar M, Hagh Jo AG, et al. Study on serum copper and zinc level of children with epilepsy during long term therapy with anticonvulsants. Life Sci J. 2012;9:1250-1254.
277. Sadeghzadeh M, Koosha A, Norouzi Pakdel M. The relation between serum zinc level and febrile seizures in children admitted to Zanjan Valie-Asr hospital. Scientific J Zanjan (Iran). 2011;19:17-24.
278. Schott GD, Delves HT. Plasma zinc levels with anticonvulsant therapy. Brit J Clin Pharmacol. 1978;5:279-280.
279. Seven M, Basaran SY, Cengiz M, et al. Deficiency of selenium and zinc as a causative factor for idiopathic intractable epilepsy. Epilepsy Res. 2013;104:35-39.
280. Smith WGJ, Bone I. Copper, zinc and magnesium plasma levels in epilepsy. J Neurol Neurosurg Psychiatr. 1982;45:1072. doi: 10.1136/jnnp.45.11.1072.
281. Sood AK, Handa R, Malhotra RC, et al. Serum, CSF, RBC & urinary levels ofmagnesium & calcium in idiopathic generalised tonic clonic seizures. Indian J Med Res. 1993;98:152-154.
282. Sozuer DT, Barutcu UB, Karakoc Y, et al. The effects of antiepileptic drugs on serum zinc and copper levels in children. J Basic Clin Physiol Pharmacol. 1995;6:265-269.
283. Suzuki T, Koizumi J, Moroji T, et al. Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatr. 1992;31:571-581.
284. Talebian A, Vakili Z, Talar SA, et al. Assessment of the relation between serum zinc & magnesium levels in children with febrile convulsion. Iran J Pathol. 2009;4:157-160.
285. Teran CG, Medows M, Wong SH, et al. Febrile seizures: current role of the laboratory investigation and source of the fever in the diagnostic approach. Pediatr Emerg Care. 2012;28:493-497.
286. Tutor JC, Fernandez P, Paz JM. Serum copper concentration and hepatic enzyme induction during long-term therapy with anticonvulsants. Clin Chem. 1982;28:1367-1370.
287. Tütüncüoğlu S, Kütükçüler N, Kepe L, et al. Proinflammatory cytokines, prostaglandins and zinc in febrile convulsions. Pediatr Int. 2001;43:235-239.
288. Ulvi H, Yiğiter R, Yoldaş T, et al. Magnesium, zinc and copper contents in hair and their serum concentrations in patients with epilepsy. East J Med. 2002;7:31-35.
289. Verrotti A, Agostinelli S, Coppola G, et al. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. Eur J Neurol. 2010;17:232-237.
290. Verrotti A, Basciani F, Trotta D, et al. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res. 2002;48:71-75.
291. Wojciak RW, Mojs E, Stanislawska-Kubiak M, et al. The serum zinc, copper, iron, and chromium concentrations in epileptic children. Epilepsy Res. 2013;104:40-44.
292. Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol. 2009;13:439-443.
293. Yuen WC, Whiteoak R, Thompson RP. Zinc concentrations in leucocytes of patients receiving antiepileptic drugs. J Clin Pathol. 1988;41:553-555.
294. Gower-Winter SD, Levenson CW. Zinc in the central nervous system: from molecules to behavior. Biofactors. 2012;38:186-193.
295. Plum LM, Rink L, Haase H. The essential toxin: impact of zinc on human health. Int J Environ Res Public Health. 2010;7:1342-1365.
296. Takeda A. Zinc homeostasis and functions of zinc in the brain. Biometals. 2001;14:343-351.
297. Khosravani H, Bladen C, Parker DB, et al. Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy. Ann Neurol. 2005;57:745-749.
298. Heron SE, Khosravani H, Varela D, et al. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol. 2007;62:560-568.
299. 2+: a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci. 2000;21:395-401.
300. Frederickson CJ, Moncrieff DW. Zinc-containing neurons. Biol Signals. 1994;3:127-139.
301. Turnlund JR. Human whole-body copper metabolism. Am J Clin Nutr. 1998;67:960S-964S.
302. Kozlowski H, Janicka-Klos A, Brasun J, et al. Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation). Coord Chem Rev. 2009;253:2665-2685.
303. Bull PC, Cox DW. Wilson disease and Menkes disease: new handles on heavymetal transport. Trends Genet. 1994;10:246-252.
304. Schlief ML, Craig AM, Gitlin JD. NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J Neurosci. 2005;25:239-246.
305. Abdelmalik PA, Politzer N, Carlen PL. Magnesium as an effective adjunct therapy for drug resistant seizures. Can J Neurol Sci. 2012;39:323-327.
306. Safar MM, Abdallah DM, Arafa NM, et al. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats. Brain Res. 2010;1334:58-64.
307. Steinbrenner H, Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system. Arch Biochem Biophys. 2013;536:152-157.
308. Naziroğlu M. Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem Res. 2009;34:2181-2191.
309. Ramaekers VT, Calomme M, Vanden Berghe D, et al. Selenium deficiency triggering intractable seizures. Neuropediatrics. 1994;25:217-223.
310. Weber GF, Maertens P, Meng X, et al. Glutathione peroxidase deficiency and childhood seizures. Lancet. 1991;337:1443-1444.